tirzepatide in the news FDA Grants a New Indication for Obesity Management Diabetes drugs semaglutide and tirzepatide

Take 1-2 capsules per day, with a meal

Kidney Impairment Semaglutide is FDA-approved to reduce the risk of Chronic Kidney Disease (CKD) worsening in individuals with Type 2 Diabetes and CKD, and it may be used under medical supervision in this group

Does spironolactone make weight loss with semaglutide harder

Research emphasizes the importance of a comprehensive treatment plan that includes MAT, highlighting its role in reducing the risk of overdose and supporting long-term sobriety

M., Bocsan, C

No dose adjustment is recommended for patients with renal or hepatic impairment, though renal function should be monitored in patients experiencing significant gastrointestinal adverse effects that could lead to dehydration